Combined Nasal, Oropharyngeal Povidone Iodine Plus Glycyrrhizic Acid Sprays, Accelerate Clinical and Laboratory Recovery and Reduces Household Transmission of SARS-CoV-2: A Randomized Placebo-Controlled Clinical Trial

Combined Nasal, Oropharyngeal Povidone Iodine Plus Glycyrrhizic Acid Sprays, Accelerate Clinical and Laboratory Recovery and Reduces Household Transmission of SARS-CoV-2: A Randomized Placebo-Controlled Clinical Trial

The COVID-19 pandemic is still posing challenging health and economic problems. Effective broad-spectrum antiviral therapy is urgently needed for the control of early SARS-CoV-2 infection to limit its spread and mutations. In this randomized placebo-controlled clinical study, we tested the effects o...

Full description

Bibliographic Details
Main Authors: Hazem E. Elsersy, Magdy A. H. Zahran, Abd-Elazeem Elbakry, Mohamed Abd-Elwahab, Mohamed Milegy Ahmed, Mohamed Salah Elgandy, Eman H. M. Mohammed, Nourhan M. Elewa
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Medicine
Subjects:
acid glycyrrhizic
iodine povidone
antiviral
SARS-CoV-2
nasal spray
oropharyngeal spray
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.863917/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.863917/full

Similar Items